E. L. Noach

811 total citations
20 papers, 436 citations indexed

About

E. L. Noach is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. L. Noach has authored 20 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. L. Noach's work include Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Hormonal and reproductive studies (3 papers). E. L. Noach is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Hormonal and reproductive studies (3 papers). E. L. Noach collaborates with scholars based in Netherlands. E. L. Noach's co-authors include P.J. Donker, W. R. O. Goslings, H. Mattie, I.L. Bonta, G. P. van Rees, J.A. Oosterhuis, E. Glasius, H J Broxterman, N.J. van Haeringen and Jan L. van Delft and has published in prestigious journals such as The Journal of Infectious Diseases, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

E. L. Noach

17 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. L. Noach Netherlands 10 151 94 90 79 64 20 436
Shachi Tyagi United States 12 249 1.6× 121 1.3× 23 0.3× 28 0.4× 64 1.0× 29 427
Céline Rouget France 15 121 0.8× 47 0.5× 71 0.8× 153 1.9× 10 0.2× 22 405
M. R. C. Vassallo Italy 13 33 0.2× 27 0.3× 29 0.3× 86 1.1× 110 1.7× 16 550
Gudrun Schober Australia 12 43 0.3× 24 0.3× 46 0.5× 140 1.8× 36 0.6× 23 456
Moses T. Tar United States 9 106 0.7× 30 0.3× 10 0.1× 72 0.9× 14 0.2× 15 327
Darakhshanda Shehnaz United States 10 32 0.2× 8 0.1× 80 0.9× 182 2.3× 13 0.2× 19 364
S. J. Downing United Kingdom 17 8 0.1× 14 0.1× 54 0.6× 192 2.4× 40 0.6× 40 899
Annemie Deiteren Belgium 16 26 0.2× 39 0.4× 71 0.8× 182 2.3× 42 0.7× 35 741
A. SJÖQVIST Sweden 17 17 0.1× 11 0.1× 388 4.3× 275 3.5× 44 0.7× 41 847
J. HARRINGTON CALKINS United States 12 16 0.1× 16 0.2× 19 0.2× 228 2.9× 42 0.7× 15 926

Countries citing papers authored by E. L. Noach

Since Specialization
Citations

This map shows the geographic impact of E. L. Noach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. L. Noach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. L. Noach more than expected).

Fields of papers citing papers by E. L. Noach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. L. Noach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. L. Noach. The network helps show where E. L. Noach may publish in the future.

Co-authorship network of co-authors of E. L. Noach

This figure shows the co-authorship network connecting the top 25 collaborators of E. L. Noach. A scholar is included among the top collaborators of E. L. Noach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. L. Noach. E. L. Noach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noach, E. L.. (1994). Appetite regulation by serotoninergic mechanisms and effects of d-fenfluramine.. PubMed. 45(3). 123–33. 24 indexed citations
2.
Noach, E. L.. (1990). The history of pharmacology in the Netherlands. Trends in Pharmacological Sciences. 11(6). 236–239. 3 indexed citations
4.
Langevelde, A. van, Hetty C. de Boer, F. M. Kaspersen, et al.. (1986). Potential radiopharmaceuticals for the detection of ocular melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 12(2). 96–104. 9 indexed citations
5.
Haeringen, N.J. van, J.A. Oosterhuis, Jan L. van Delft, E. Glasius, & E. L. Noach. (1982). A comparison of the effects of non-steroidal compounds on the disruption of the blood-aquous barrier. Experimental Eye Research. 35(3). 271–277. 24 indexed citations
6.
Broxterman, H J, E. L. Noach, & D. De Vos. (1980). Assay of HA-966 in rat plasma by capillary gas—liquid chromatography with nitrogen-selective detection. Journal of Chromatography B Biomedical Sciences and Applications. 183(2). 185–191. 2 indexed citations
7.
Broxterman, H J, et al.. (1980). HA-966 effects on striatal dopamine metabolism: implications for dopamine compartmentalization. Journal of Pharmacy and Pharmacology. 32(1). 67–69. 13 indexed citations
8.
Alphen, C. C. Kok-Van, et al.. (1976). Endocrine Influences on the Refraction of the Eyes of Young Rats. Ophthalmologica. 173(3-4). 328–332.
9.
Mattie, H., W. R. O. Goslings, & E. L. Noach. (1973). Cloxacillin and Nafcillin: Serum Binding and Its Relationship to Antibacterial Effect in Mice. The Journal of Infectious Diseases. 128(2). 170–177. 52 indexed citations
10.
Donker, P.J., et al.. (1972). ANALYSES OF THE URETHRAL PRESSURE PROFILE BY MEANS OF ELECTROMYOGRAPHY AND THE ADMINISTRATION OF DRUGS. British Journal of Urology. 44(2). 180–193. 197 indexed citations
11.
Bonta, I.L., et al.. (1971). 1‐Hydroxy‐3‐amino‐pyrrolidone‐2 (HA‐966): a new GABA‐like compound, with potential use in extrapyramidal diseases. British Journal of Pharmacology. 43(3). 514–535. 58 indexed citations
12.
Noach, E. L., et al.. (1971). The influence of 1-hydroxy-3-amino-pyrrolidinone-2 (HA-966) on dopamine metabolism in the rat corpus striatum. European Journal of Pharmacology. 16(2). 222–224. 15 indexed citations
13.
Driessen, O. & E. L. Noach. (1969). EFFECT OF TESTOSTERONE PROPIONATE ON THE DISTRIBUTION OF RADIOACTIVE IODIDE IN RECENTLY THYROIDECTOMIZED RATS. European Journal of Endocrinology. 60(2). 303–314. 1 indexed citations
14.
Driessen, O. & E. L. Noach. (1968). Effect of testosterone propionate on the renal excretion of iodide-131 in the rat. European Journal of Pharmacology. 3(3). 257–262.
15.
Noach, E. L., et al.. (1968). Absence of modification of tyramine pressor effects by octopamine in reserpinized rats. European Journal of Pharmacology. 3(1). 78–80. 1 indexed citations
16.
Rees, G. P. van, E. L. Noach, & J. A. M. J. van Dieten. (1965). INFLUENCE OF TESTOSTERONE ON THE SECRETION OF THYROTROPHIN IN THE RAT. European Journal of Endocrinology. 50(1). 155–160. 11 indexed citations
17.
Noach, E. L. & G. P. van Rees. (1958). ASCORBIC ACID IN THE GONADS OF RATS. European Journal of Endocrinology. 27(4). 502–508. 6 indexed citations
18.
Noach, E. L., et al.. (1957). INSULIN DEFICIENCY AND DIABETES. European Journal of Endocrinology. 25(1). 91–100. 4 indexed citations
19.
Noach, E. L.. (1955). INFLUENCE OF OESTROGENS ON THYROID FUNCTION. I.. European Journal of Endocrinology. 19(2). 127–138. 12 indexed citations
20.
Noach, E. L.. (1955). INFLUENCE OF OESTROGENS ON THYROID FUNCTION. II.. European Journal of Endocrinology. 19(2). 139–151. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026